Genetic testing of embryos is an option available to patients during the IVF process. In addition to ensuring a healthy future for your child, genetic testing of embryos can help to improve pregnancy success rates, as the cause of early pregnancy loss or lack of embryo implantation can often be attributed to genetic abnormalities.
Preimplantation Genetic Testing for Aneuploidy (PGT-A), formerly known as Preimplantation Genetic Screening (PGS), looks for chromosomal abnormalities in embryos. This can help identify or rule out certain chromosome disorders, such as trisomy 13, 18, and 21 (Downs syndrome). This technology can also determine the sex of the embryos prior to implantation.
Preimplantation Genetic Testing for Monogenic Disorders (PGT-M), formerly known as Preimplantation Genetic Disorders (PGD), detects genetically inherited disorders in embryos, such as cystic fibrosis or tay sachs, when both partners are found to be carriers for a specific genetic disease.Learn More
Preimplantation Genetic Testing for Structural Rearrangement (PGT-SR) detects balanced chromosome structural rearrangement such as reciprocal translocation or inversion, which may be a cause of recurrent pregnancy loss.